{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T00:02:01Z","timestamp":1787702521434,"version":"build-2784847793"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T00:00:00Z","timestamp":1653868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Adverse drug reactions (ADRs) account for 10% of acute hospital admissions in older people, often under-recognised by physicians. The Dutch geriatric guideline recommends screening all acutely admitted older patients with polypharmacy with an ADR trigger tool comprising ten triggers and associated drugs frequently causing ADRs. This study investigated the performance of this tool and the recognition by usual care of ADRs detected with the tool.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A cross-sectional study was performed in patients\u2009\u2265\u200970\u00a0years with polypharmacy acutely admitted to the geriatric ward of the University Medical Centre Utrecht. Electronic health records (EHRs) were screened for trigger\u2013drug combinations listed in the ADR trigger tool. Two independent appraisers assessed causal probability with the WHO-UMC algorithm and screened EHRs for recognition of ADRs by attending physicians. Performance of the tool was defined as the positive predictive value (PPV) for ADRs with a possible, probable or certain causal relation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 941 trigger\u2013drug combinations were present in 73% (<jats:italic>n<\/jats:italic>\u2009=\u2009253\/345) of the patients. The triggers fall, delirium, renal insufficiency and hyponatraemia covered 86% (<jats:italic>n<\/jats:italic>\u2009=\u2009810\/941) of all trigger\u2013drug combinations. The overall PPV was 41.8% (<jats:italic>n<\/jats:italic>\u2009=\u2009393\/941), but the PPV for individual triggers was highly variable ranging from 0 to 100%. Usual care recognised the majority of ADRs (83.5%), increasing to 97.1% when restricted to possible and certain ADRs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The ADR trigger tool has predictive value; however, its implementation is unlikely to improve the detection of unrecognised ADRs in older patients acutely admitted to our geriatric ward. Future research is needed to investigate the tool\u2019s clinical value when applied to older patients acutely admitted to non-geriatric wards.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s41999-022-00649-x","type":"journal-article","created":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T06:02:32Z","timestamp":1653890552000},"page":"837-847","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Performance of a trigger tool for detecting adverse drug reactions in patients with polypharmacy acutely admitted to the geriatric ward"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0719-1618","authenticated-orcid":false,"given":"Nikki M. F.","family":"Noorda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bastiaan T. G. M.","family":"Sallevelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wivien L.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toine C. G.","family":"Egberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eug\u00e8ne P.","family":"van Puijenbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingeborg","family":"Wilting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilma","family":"Knol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,30]]},"reference":[{"key":"649_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12596","author":"EA Davies","year":"2015","unstructured":"Davies EA, O\u2019Mahony MS (2015) Adverse drug reactions in special populations\u2014the elderly. Br J Clin Pharmacol. https:\/\/doi.org\/10.1111\/bcp.12596","journal-title":"Br J Clin Pharmacol"},{"key":"649_CR2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.2003.02007.x","author":"AA Mangoni","year":"2004","unstructured":"Mangoni AA, Jackson SHD (2004) Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol. https:\/\/doi.org\/10.1046\/j.1365-2125.2003.02007.x","journal-title":"Br J Clin Pharmacol"},{"key":"649_CR3","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/s41999-021-00481-9","volume":"12","author":"MB Zazzara","year":"2021","unstructured":"Zazzara MB, Palmer K, Vetrano DL, Carf\u00ec A, Graziano O (2021) Adverse drug reactions in older adults: a narrative review of the literature. Eur Geriatr Med 12:463\u2013473. https:\/\/doi.org\/10.1007\/s41999-021-00481-9","journal-title":"Eur Geriatr Med"},{"key":"649_CR4","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-017-2225-3","author":"TJ Oscanoa","year":"2017","unstructured":"Oscanoa TJ, Lizaraso F, Carvajal A (2017) Hospital admissions due to adverse drug reactions in the elderly. A meta-analysis. Eur J Clin Pharmacol. https:\/\/doi.org\/10.1007\/s00228-017-2225-3","journal-title":"Eur J Clin Pharmacol"},{"key":"649_CR5","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S71178","author":"TM Alhawassi","year":"2014","unstructured":"Alhawassi TM, Krass I, Bajorek B, Pont LG (2014) A systematic review of the prevalence and risk factors for adverse drug reactions in the elderly in the acute care setting. Clin Interv Aging. https:\/\/doi.org\/10.2147\/CIA.S71178","journal-title":"Clin Interv Aging"},{"key":"649_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/j.jemermed.2013.11.124","volume":"46","author":"L Roulet","year":"2014","unstructured":"Roulet L, Ballereau F, Hardouin JB, Chiffoleau A, Potel G, Asseray N (2014) Adverse drug event nonrecognition in emergency departments: an exploratory study on factors related to patients and drugs. J Emerg Med 46:857\u2013864. https:\/\/doi.org\/10.1016\/j.jemermed.2013.11.124","journal-title":"J Emerg Med"},{"key":"649_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1757-7241-21-15","volume":"21","author":"CH Nickel","year":"2013","unstructured":"Nickel CH, Ruedinger JM, Messmer AS, Maile S, Peng A, Bodmer M et al (2013) Drug\u2014related emergency department visits by elderly patients presenting with non-specific complaints. Scand J Trauma Resusc Emerg Med 21:1. https:\/\/doi.org\/10.1186\/1757-7241-21-15","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"649_CR8","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.annemergmed.2009.10.008","volume":"55","author":"CM Hohl","year":"2010","unstructured":"Hohl CM, Zed PJ, Brubacher JR, Abu-Laban RB, Loewen PS, Purssell RA (2010) Do emergency physicians attribute drug-related emergency department visits to medication-related problems? Ann Emerg Med 55:493-502.e4. https:\/\/doi.org\/10.1016\/j.annemergmed.2009.10.008","journal-title":"Ann Emerg Med"},{"key":"649_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2147\/CIA.S99097","volume":"11","author":"NP Nair","year":"2016","unstructured":"Nair NP, Chalmers L, Peterson GM, Bereznicki BJ, Castelino RL, Bereznicki LR (2016) Hospitalization in older patients due to adverse drug reactions\u2014the need for a prediction tool. Clin Interv Aging 11:497\u2013505. https:\/\/doi.org\/10.2147\/CIA.S99097","journal-title":"Clin Interv Aging"},{"key":"649_CR10","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","volume":"170","author":"G Onder","year":"2010","unstructured":"Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, Somers A et al (2010) Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 170:1142\u20131148. https:\/\/doi.org\/10.1001\/archinternmed.2010.153","journal-title":"Arch Intern Med"},{"key":"649_CR11","unstructured":"Griffin F, Resar R (2007) IHI global trigger tool for measuring adverse events. IHI Innov Ser White Pap. pp.1\u201344.\nhttp:\/\/www.ihi.org\/resources\/Pages\/Tools\/IntrotoTriggerToolsforIdentifyingAEs.aspx. Accessed 24 May 2022"},{"key":"649_CR12","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1177\/1060028013500939","volume":"47","author":"L Carnevali","year":"2013","unstructured":"Carnevali L, Krug B, Amant F, Van Pee D, Gerard V, de Bethune X et al (2013) Performance of the adverse drug event trigger tool and the global trigger tool for identifying adverse drug events: experience in a belgian hospital. Ann Pharmacother 47:1414\u20131419. https:\/\/doi.org\/10.1177\/1060028013500939","journal-title":"Ann Pharmacother"},{"key":"649_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/pts.0000000000000552","volume":"2","author":"MD Toscano Guzm\u00e1n","year":"2018","unstructured":"Toscano Guzm\u00e1n MD, Galv\u00e1n Banqueri M, Otero MJ, S\u00e1nchez Fidalgo S, Font Noguera I, P\u00e9rez Guerrero MC (2018) Validating a trigger tool for detecting adverse drug events in elderly patients with multimorbidity (TRIGGER-CHRON). J Patient Saf 2:1\u20137. https:\/\/doi.org\/10.1097\/pts.0000000000000552","journal-title":"J Patient Saf"},{"key":"649_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2019-002126","author":"MJ Otero","year":"2020","unstructured":"Otero MJ, Toscano Guzm\u00e1n MD, Galv\u00e1n-Banqueri M, Martinez-Sotelo J, Santos-Rubio MD (2020) Utility of a trigger tool (TRIGGER-CHRON) to detect adverse events associated with high-alert medications in patients with multimorbidity. Eur J Hosp Pharm. https:\/\/doi.org\/10.1136\/ejhpharm-2019-002126","journal-title":"Eur J Hosp Pharm"},{"key":"649_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/qshc.2007.024406","volume":"18","author":"R Singh","year":"2009","unstructured":"Singh R, McLean-Plunckett EA, Kee R, Wisniewski A, Cadzow R, Okazaki S et al (2009) Experience with a trigger tool for identifying adverse drug events among older adults in ambulatory primary care. Qual Saf Heal Care 18:199\u2013204. https:\/\/doi.org\/10.1136\/qshc.2007.024406","journal-title":"Qual Saf Heal Care"},{"key":"649_CR16","unstructured":"Dutch society for geriatric medicine. Multidisciplinary guideline for polpharmacy in older people. Addendum: polypharmacy optimisation in hospitalised older people. 2017:1\u2013166. https:\/\/richtlijnendatabase.nl\/richtlijn\/polyfarmacie_bij_ouderen\/polyfarmacie_bij_ouderen_2e_lijn.html (last Accessed: 16-03-2022)"},{"key":"649_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3747","author":"MF Warl\u00e9-van Herwaarden","year":"2015","unstructured":"Warl\u00e9-van Herwaarden MF, Valkhoff VE, Herings RMC, Engelkes M, Van Blijderveen JC, Rodenburg EM et al (2015) Quick assessment of drug-related admissions over time (QUADRAT study). Pharmacoepidemiol Drug Saf. https:\/\/doi.org\/10.1002\/pds.3747","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"649_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2165\/11596000-000000000-00000","volume":"35","author":"MF Warl\u00e9-van Herwaarden","year":"2012","unstructured":"Warl\u00e9-van Herwaarden MF, Kramers C, Sturkenboom MC, van den Bemt PMLA, De Smet PAGM (2012) Targeting outpatient drug safety. Drug Saf 35:245\u2013259. https:\/\/doi.org\/10.2165\/11596000-000000000-00000","journal-title":"Drug Saf"},{"key":"649_CR19","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.73.864.635","author":"FE Shaw","year":"1997","unstructured":"Shaw FE, Kenny RA (1997) The overlap between syncope and falls in the elderly. Postgrad Med J. https:\/\/doi.org\/10.1136\/pgmj.73.864.635","journal-title":"Postgrad Med J"},{"key":"649_CR20","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2165\/00002018-200831010-00003","volume":"31","author":"T Agbabiaka","year":"2008","unstructured":"Agbabiaka T, Savovic J, Ernst E (2008) Methods for causality assessment. Drug Saf 31:21\u201337","journal-title":"Drug Saf"},{"key":"649_CR21","unstructured":"Center WHO-UMC (2009) WHO Causality assessment. Good Pharmacovigil Pract Guid. p. 39. https:\/\/www.who.int\/publications\/m\/item\/WHO-causality-assessment. Accessed 24 May 2022"},{"key":"649_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13716","author":"S Thevelin","year":"2018","unstructured":"Thevelin S, Spinewine A, Beuscart JB, Boland B, Marien S, Vaillant F et al (2018) Development of a standardized chart review method to identify drug-related hospital admissions in older people. Br J Clin Pharmacol. https:\/\/doi.org\/10.1111\/bcp.13716","journal-title":"Br J Clin Pharmacol"},{"key":"649_CR23","doi-asserted-by":"publisher","DOI":"10.2307\/2529310","author":"JR Landis","year":"1977","unstructured":"Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics. https:\/\/doi.org\/10.2307\/2529310","journal-title":"Biometrics"},{"issue":"1","key":"649_CR24","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1186\/s12877-021-02532-z","volume":"21","author":"L Zerah","year":"2021","unstructured":"Zerah L, Henrard S, Wilting I et al (2021) Prevalence of drug-drug interactions in older people before and after hospital admission: analysis from the OPERAM trial. BMC Geriatr 21(1):571. https:\/\/doi.org\/10.1186\/s12877-021-02532-z","journal-title":"BMC Geriatr"},{"key":"649_CR25","doi-asserted-by":"publisher","DOI":"10.1097\/pts.0000000000000820","author":"F Marseau","year":"2021","unstructured":"Marseau F, Prud\u2019Homm J, Bouzill\u00e9 G, Polard E, Oger E, Somme D et al (2021) The trigger tool method for routine pharmacovigilance. J Patient Saf. https:\/\/doi.org\/10.1097\/pts.0000000000000820","journal-title":"J Patient Saf"},{"key":"649_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/ageing\/afu145","volume":"44","author":"D O\u2019mahony","year":"2015","unstructured":"O\u2019mahony D, O\u2019sullivan D, Byrne S, O\u2019connor MN, Ryan C, Gallagher P (2015) STOPP\/START criteria for potentially inappropriate prescribing in older people: version 2. Age Ageing 44:213\u2013218. https:\/\/doi.org\/10.1093\/ageing\/afu145","journal-title":"Age Ageing"},{"key":"649_CR27","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1093\/ageing\/afaa249","volume":"50","author":"LJ Seppala","year":"2021","unstructured":"Seppala LJ, Petrovic M, Ryg J, Bahat G, Topinkova E, Szczerbinska K et al (2021) STOPPFall (screening tool of older persons prescriptions in older adults with high fall risk): a delphi study by the EuGMS task and finish group on fall-risk-increasing drugs. Age Ageing 50:1189\u20131199. https:\/\/doi.org\/10.1093\/ageing\/afaa249","journal-title":"Age Ageing"},{"key":"649_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ageing\/afab205","volume":"51","author":"BA Damoiseaux-Volman","year":"2022","unstructured":"Damoiseaux-Volman BA, Raven K, Sent D, Medlock S, Romijn JA, Abu-Hanna A et al (2022) Potentially inappropriate medications and their effect on falls during hospital admission. Age Ageing 51:1\u20138. https:\/\/doi.org\/10.1093\/ageing\/afab205","journal-title":"Age Ageing"},{"key":"649_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.2146\/ajhp100019","volume":"68","author":"C Meyer-Massetti","year":"2011","unstructured":"Meyer-Massetti C, Cheng CM, Schwappach DLB, Paulsen L, Ide B, Meier CR et al (2011) Systematic review of medication safety assessment methods. Am J Heal Pharm 68:227\u2013240. https:\/\/doi.org\/10.2146\/ajhp100019","journal-title":"Am J Heal Pharm"},{"key":"649_CR30","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2165\/00002512-200320100-00005","volume":"20","author":"T Egger","year":"2003","unstructured":"Egger T, Dormann H, Ahne G, Runge U, Neubert A, Criegee-Rieck M et al (2003) Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drugs Aging 20:769\u2013776. https:\/\/doi.org\/10.2165\/00002512-200320100-00005","journal-title":"Drugs Aging"},{"key":"649_CR31","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200022020-00007","author":"H Dormann","year":"2000","unstructured":"Dormann H, Muth-Selbach U, Krebs S, Criegee-Rieck M, Tegeder I, Thomas Schneider H et al (2000) Incidence and costs of adverse drug reactions during hospitalization. Computerised monitoring versus stimulated spontaneous reporting. Drug Saf. https:\/\/doi.org\/10.2165\/00002018-200022020-00007","journal-title":"Drug Saf"},{"key":"649_CR32","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1365-2036.2004.01854.x","volume":"19","author":"H Dormann","year":"2004","unstructured":"Dormann H, Criegee-Rieck M, Neubert A, Egger T, Levy M, Hahn EG et al (2004) Implementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterology. Aliment Pharmacol Ther 19:303\u2013309. https:\/\/doi.org\/10.1111\/j.1365-2036.2004.01854.x","journal-title":"Aliment Pharmacol Ther"},{"key":"649_CR33","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200623100-00005","author":"SS Egger","year":"2006","unstructured":"Egger SS, Bachmann A, Hubmann N, Schlienger RG, Kr\u00e4henb\u00fchl S (2006) Prevalence of potentially inappropriate medication use in elderly patients: comparison between general medical and geriatric wards. Drugs Aging. https:\/\/doi.org\/10.2165\/00002512-200623100-00005","journal-title":"Drugs Aging"},{"key":"649_CR34","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00228-012-1316-4","volume":"69","author":"JE Klopotowska","year":"2013","unstructured":"Klopotowska JE, Wierenga PC, Smorenburg SM, Stuijt CCM, Arisz L, Kuks PFM et al (2013) Recognition of adverse drug events in older hospitalized medical patients. Eur J Clin Pharmacol 69:75\u201385. https:\/\/doi.org\/10.1007\/s00228-012-1316-4","journal-title":"Eur J Clin Pharmacol"},{"key":"649_CR35","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.15.1666","author":"CMJ Van Der Linden","year":"2006","unstructured":"Van Der Linden CMJ, Kerskes MCH, Bijl AMH, Maas HAAM, Egberts ACG, Jansen PAF (2006) Represcription after adverse drug reaction in the elderly: a descriptive study. Arch Intern Med. https:\/\/doi.org\/10.1001\/archinte.166.15.1666","journal-title":"Arch Intern Med"},{"key":"649_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/11631760-000000000-00000","volume":"29","author":"M Petrovic","year":"2012","unstructured":"Petrovic M, Van Der Cammen T, Onder G (2012) Adverse drug reactions in older people: detection and prevention. Drugs Aging 29:453\u2013462. https:\/\/doi.org\/10.2165\/11631760-000000000-00000","journal-title":"Drugs Aging"},{"key":"649_CR37","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40266-018-0554-2","volume":"35","author":"D Mangin","year":"2018","unstructured":"Mangin D, Bahat G, Golomb BA, Mallery LH, Moorhouse P, Onder G et al (2018) International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drugs Aging 35:575\u2013587. https:\/\/doi.org\/10.1007\/s40266-018-0554-2","journal-title":"Drugs Aging"},{"key":"649_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s41999-018-0030-x","volume":"9","author":"D O\u2019Mahony","year":"2018","unstructured":"O\u2019Mahony D, O\u2019Connor MN, Eustace J, Byrne S, Petrovic M, Gallagher P (2018) The adverse drug reaction risk in older persons (ADRROP) prediction scale: derivation and prospective validation of an ADR risk assessment tool in older multi-morbid patients. Eur Geriatr Med 9:191\u2013199. https:\/\/doi.org\/10.1007\/s41999-018-0030-x","journal-title":"Eur Geriatr Med"},{"key":"649_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.ssci.2021.105355","volume":"142","author":"BA Damoiseaux-Volman","year":"2021","unstructured":"Damoiseaux-Volman BA, Medlock S, van der Eijk MD, Romijn JA, Abu-Hanna A, van der Velde N (2021) Falls and delirium in older inpatients: Work-as-imagined, work-as-done and preferences for clinical decision support systems. Saf Sci 142:105355. https:\/\/doi.org\/10.1016\/j.ssci.2021.105355","journal-title":"Saf Sci"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-022-00649-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-022-00649-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-022-00649-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T08:17:30Z","timestamp":1661329050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-022-00649-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,30]]},"references-count":39,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,8]]}},"alternative-id":["649"],"URL":"https:\/\/doi.org\/10.1007\/s41999-022-00649-x","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,30]]},"assertion":[{"value":"23 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The Research Ethics Committee of University Medical Centre Utrecht confirmed that the Medical Research Involving Human Subjects Act was not applicable to this study, and a waiver was granted (no. WAG\/mb\/17\/024864).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}